grant

Engineering durable immunity by optimizing HIV vaccine parameters to drive long-lived plasma cell development

Organization SCRIPPS RESEARCH INSTITUTE, THELocation LA JOLLA, UNITED STATESPosted 21 Aug 2025Deadline 31 Jul 2030
NIHUS FederalResearch GrantFY2025AIDSAIDS VirusAIDS/HIVAb responseAccelerationAcquired Immune DeficiencyAcquired Immune Deficiency SyndromeAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency SyndromeAcquired Immunodeficiency Syndrome VirusAdjuvantAffectAffinityAgreementAnti-Retroviral AgentsAntibodiesAntibody FormationAntibody ProductionAntibody ResponseAntigensB blood cellsB cellB cell repertoireB cellsB-CellsB-LymphocytesB-cellBlood Plasma CellBolusBolus InfusionBone MarrowBone Marrow Reticuloendothelial SystemCell LineageClinicalCommunicable DiseasesCompensationControlled EnvironmentDataDevelopmentDiseaseDisorderDoseDrugsEngineeringFlu vaccinationFutureGeneticGerminal CenterHIVHIV InfectionsHIV vaccineHIV/AIDSHIV/AIDS VaccinesHTLV-III InfectionsHTLV-III-LAV InfectionsHalf-LifeHealth PrioritiesHuman Immunodeficiency VirusesHuman T-Lymphotropic Virus Type III InfectionsHumoral ImmunitiesImmune responseImmune systemImmunityImmunizationInfectionInfectious DiseasesInfectious DisorderInfluenza immunizationInfluenza vaccinationInjectionsLAV-HTLV-IIILengthLifeLinkLiposomalLiposomesLymphadenopathy-Associated VirusMeasles VaccineMeasles virus vaccineMeasuresMediatingMedicationMemory B CellMemory B-LymphocyteMessenger RNAMethodsPersonsPharmaceutical PreparationsPlasma CellsPlasmacytesPlayPopulationPreventionProductionPropertyProphylactic treatmentProphylactic vaccination against influenzaProphylaxisProteinsRNA vaccineRNA-based vaccineReactionRegimenResearchResistanceRoleScheduleSpottingsStructureStructure of germinal center of lymph nodeTherapeutic InterventionTimeVaccinationVaccination acquired immunityVaccination induced immunityVaccinesVariantVariationViralVirus-HIVaccess to vaccinationaccess to vaccinesanti-retroviralantibody biosynthesisantibody-based immunityartificial environmentclinical relevanceclinically relevantdeliver mRNAdeliver messenger RNAdelivery system for mRNAdesigndesigningdevelop a vaccinedevelop vaccinesdevelopment of a vaccinedevelopmentaldrug/agentflu immunisationglobal healthhost responsehuman immunodeficiency virus vaccineimmune system responseimmunization against measlesimmunogenimmunoglobulin biosynthesisimmunoresponseinfluenza virus vaccinationinnovateinnovationinnovativeintervention therapylife spanlifespanlipid based nanoparticlelipid nanoparticlemRNAmRNA deliverymRNA vaccinemRNA-based vaccinemessenger RNA deliverynano particlenano-sized particlenanoparticlenanosized particleneutralizing antibodypandemicpandemic diseaseplasma cell developmentplasmocyteprimary end pointprimary endpointresistantresponseseasonal fluseasonal influenzasocial rolevaccination accessvaccination against influenzavaccination availabilityvaccination studyvaccination trialvaccine accessvaccine acquired immunityvaccine against measlesvaccine associated immunityvaccine availabilityvaccine developmentvaccine formulationvaccine platformvaccine studyvaccine trialvaccine-induced immunityvaccine-induced protection
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

PROJECT SUMMARY
The HIV pandemic has been raging for nearly forty years, and despite immense effort we have yet to discover a

vaccine that can induce durable, protective immunity. HIV remains an urgent global health crisis, with 38 million

people living with HIV and 1.5 million people newly infected each year. For most infectious diseases but…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →